1. Home
  2. PSEC vs ALVO Comparison

PSEC vs ALVO Comparison

Compare PSEC & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prospect Capital Corporation

PSEC

Prospect Capital Corporation

HOLD

Current Price

$2.34

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.79

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSEC
ALVO
Founded
2004
2013
Country
United States
Luxembourg
Employees
8
1460
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PSEC
ALVO
Price
$2.34
$3.79
Analyst Decision
Sell
Buy
Analyst Count
1
4
Target Price
$2.50
$8.00
AVG Volume (30 Days)
4.5M
785.0K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
20.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$13.28
Revenue Next Year
N/A
$18.63
P/E Ratio
N/A
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$2.11
$2.94
52 Week High
$3.13
$9.25

Technical Indicators

Market Signals
Indicator
PSEC
ALVO
Relative Strength Index (RSI) 47.98 57.03
Support Level $2.15 $3.10
Resistance Level $2.35 $4.02
Average True Range (ATR) 0.07 0.23
MACD 0.01 0.07
Stochastic Oscillator 50.11 70.37

Price Performance

Historical Comparison
PSEC
ALVO

About PSEC Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: